RAC1 and breast cancer: Interestingly, Li et al. suggest another DDR mechanism in which breast cancer cells overcome chemotherapeutic resistance via metabolism, stating the RAC1 overexpression after chemotherapy exposure led breast cancer cells to activate aldolase and ERK signaling, upregulating glycolysis and the pentose-phosphate pathway.